Led by Drs. Cherry, Fajgenbaum and Miner, HIT-AI uses knowledge graphs, ML and high-throughput screening to identify repurposed treatments across 160+ autoimmune diseases, evaluating 4,000 FDA-approved drugs from screening to clinical trials — a scalable model for the future of #autoimmunity.
The Colton Center for Autoimmunity, University of Pennsylvania
Dr. Sara Cherry shared progress from the High-Throughput Center for Autoimmune Therapeutic Discovery (HIT-AI), a Colton Center of Excellence. Working with collaborators, Dr. Fajgenbaum and Dr. Miner, the center combines #AI with high-throughput screening to identify new #autoimmune therapies.
